Dendritic cells from bench to bedside and back

被引:76
作者
Adema, G. J. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Tumorimmunol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands
关键词
Dendritic cells; Immunotherapy; Vaccines; Toll-like-receptors; Cancer; REGULATORY T-CELLS; MELANOMA PATIENTS; IMMUNE-RESPONSES; LYMPH-NODES; IN-VIVO; ANTIGEN; MATURATION; MIGRATION; RNA;
D O I
10.1016/j.imlet.2008.11.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Dendritic cells (DCs) are the most potent antigen-presenting cells of the immune system. They serve as the sentinels that capture antigens in the periphery, process them into peptides and present these to lymphocytes in lymph nodes. DCs play a key role in regulating immunity. Several DC-subsets exist, including myeloid-DCs (MDCs), plasmacytoid-DCs (PDCs) and Langerhans cells (LQ. DCs not only instruct T- and B-lymphocytes, but also activate Natural Killer cells and produce interferons, thus linking the innate and adaptive immune system. Inflammatory-mediators and especially the Toll like receptor (TLR) family of proteins have been shown to play a pivotal role in inducing the immune activation program in DCs. TLRs recognize pathogen-associated-molecular-patterns (PAMPS) like LPS or flagellin and signal to alert immune cells in general, and DC in particular. DC activation, also referred to as DC maturation, thus results in immunity. In contrast, resting DC or DC receiving immune-inhibitory signals. like IL-10 and/or corticosteroids, induce immune tolerance via T cell deletion and induction of suppressive T cells, now termed regulatory T cells. Several mouse models have demonstrated that the immunological outcome is depending on the DC activation state; mature immune-activating DC protect mice from a tumor or pathogen while tolerogenic DC induces tolerance against transplanted tissues. Hence, DC acts at the interface of immunity and peripheral tolerance. (C) 2008 Published by Elsevier B.V.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 15 条
[1]
Migration of dendritic cell based cancer vaccines:: in vivo veritas? [J].
Adema, GJ ;
de Vries, IJM ;
Punt, CJA ;
Figdor, CG .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (02) :170-174
[2]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration [J].
Boullart, A. C. Inge ;
Aarntzen, Erik H. J. G. ;
Verdijk, Pauline ;
Jacobs, Joannes F. M. ;
Schuurhuis, Danita H. ;
Benitez-Ribas, Daniel ;
Schreibelt, Gerty ;
van de Rakt, Mandy W. M. M. ;
Scharenborg, Nicole M. ;
de Boer, Annemiek ;
Kramer, Matthijs ;
Figdor, Carl G. ;
Punt, Cornelis J. A. ;
Adema, Gosse J. ;
de Vries, I. Jolanda M. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (11) :1589-1597
[4]
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[5]
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome [J].
de Vries, IJM ;
Bernsen, MR ;
Lesterhuis, WJ ;
Scharenborg, NM ;
Strijk, SP ;
Gerritsen, MJP ;
Ruiter, DJ ;
Figdor, CG ;
Punt, CJA ;
Adema, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5779-5787
[6]
de Vries IJM, 2003, CANCER RES, V63, P12
[7]
de Vries IJM, 2003, CLIN CANCER RES, V9, P5091
[8]
Dendritic cell immunotherapy: mapping the way [J].
Figdor, CG ;
de Vries, IJM ;
Lesterhuis, WJ ;
Melief, CJM .
NATURE MEDICINE, 2004, 10 (05) :475-480
[9]
CD4+FoxP3+regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo [J].
Grauer, Oliver M. ;
Nierkens, Stefan ;
Bennink, Erik ;
Toonen, Liza W. J. ;
Boon, Louis ;
Wesseling, Pieter ;
Sutmuller, Roger P. M. ;
Adema, Gosse J. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (01) :95-105
[10]
JACOBS JF, 2008, NEURO ONCOL